Evotec

Life Sciences Tools & Services / Pharmaceuticals
EVT.DE
€ 14 (1.3)%
Share price
$ 2.7 bn
Market Cap
$ 2.7 bn
Enterprise Value

Carbon footprint

0.03 Ton
GHG emissions per $ 1 mln investment
0x the weighted average for S&P 500
FY2021
How is this calculated?
-67%
YOY change in GHG emissions
Stronger than the -11% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Evotec's GHG emissions (market-based) (Kt of CO2e)
Evotec's Carbon intensity (Tons per 1 USDm)

Evotec's carbon footprint

Evotec reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 0.07 Kt (-0.14 /-66.6% y-o-y). Also positively, carbon intensity declined to 0.1 t (-0.3 /-75% y-o-y).

Evotec reported Scope 3 emissions for the the twelve months ending31 December 2021 at 0.32

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Evotec also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Evotec SE commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by 2032 from a 2021 base year. Evotec SE also commits to increase active annual sourcing of renewable electricity from 25% in 2021 to 100% by 2026, and to continue active annual sourcing of 100% renewable electricity through 2030. Evotec SE further commits to reduce scope 3 GHG from purchased goods and services and capital goods 72% per million EUR value added by 2032 from a 2021 base year. Evotec commits that 80% of its suppliers by emissions covering purchased goods and services and capital goods will have science-based targets by 2027.

Company environmental metrics

Show more...